Estimating Neonatal Herpes Simplex Virus Incidence and Mortality Using Capture-recapture, Florida.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
02 08 2021
Historique:
received: 30 12 2019
accepted: 03 06 2020
pubmed: 9 6 2020
medline: 7 8 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

Neonatal herpes simplex virus infection (nHSV) leads to severe morbidity and mortality, but national incidence is uncertain. Florida regulations require that healthcare providers report cases, and clinical laboratories report test results when herpes simplex virus (HSV) is detected. We estimated nHSV incidence using laboratory-confirmed provider-reported cases and electronic laboratory reports (ELR) stored separately from provider-reported cases. Mortality was estimated using provider-reported cases, ELR, and vital statistics death records. For 2011-2017, we reviewed: provider-reported cases (infants ≤ 60 days of age with HSV infection confirmed by culture or polymerase chain reaction [PCR]), ELR of HSV-positive culture or PCR results in the same age group, and death certificates containing International Classification of Disease, Tenth Revision, codes for herpes infection: P35.2, B00.0-B00.9, and A60.0-A60.9. Provider-reported cases were matched against ELR reports. Death certificates were matched with provider and ELR reports. Chapman's capture-recapture method was used to estimate nHSV incidence and mortality. Mortality from all 3 sources was estimated using log-linear modeling. Providers reported 114 nHSV cases, and ELR identified 197 nHSV cases. Forty-six cases were common to both datasets, leaving 265 unique nHSV reports. Chapman's estimate suggests 483 (95% confidence interval [CI], 383-634) nHSV cases occurred (31.5 infections per 100 000 live births). The nHSV deaths were reported by providers (n = 9), ELR (n = 18), and vital statistics (n = 31), totaling 34 unique reports. Log-linear modeling estimates 35.8 fatal cases occurred (95% CI, 34-40). Chapman's estimates using data collected over 7 years in Florida conclude nHSV infections occurred at a rate of 1 per 3000 live births.

Sections du résumé

BACKGROUND
Neonatal herpes simplex virus infection (nHSV) leads to severe morbidity and mortality, but national incidence is uncertain. Florida regulations require that healthcare providers report cases, and clinical laboratories report test results when herpes simplex virus (HSV) is detected. We estimated nHSV incidence using laboratory-confirmed provider-reported cases and electronic laboratory reports (ELR) stored separately from provider-reported cases. Mortality was estimated using provider-reported cases, ELR, and vital statistics death records.
METHODS
For 2011-2017, we reviewed: provider-reported cases (infants ≤ 60 days of age with HSV infection confirmed by culture or polymerase chain reaction [PCR]), ELR of HSV-positive culture or PCR results in the same age group, and death certificates containing International Classification of Disease, Tenth Revision, codes for herpes infection: P35.2, B00.0-B00.9, and A60.0-A60.9. Provider-reported cases were matched against ELR reports. Death certificates were matched with provider and ELR reports. Chapman's capture-recapture method was used to estimate nHSV incidence and mortality. Mortality from all 3 sources was estimated using log-linear modeling.
RESULTS
Providers reported 114 nHSV cases, and ELR identified 197 nHSV cases. Forty-six cases were common to both datasets, leaving 265 unique nHSV reports. Chapman's estimate suggests 483 (95% confidence interval [CI], 383-634) nHSV cases occurred (31.5 infections per 100 000 live births). The nHSV deaths were reported by providers (n = 9), ELR (n = 18), and vital statistics (n = 31), totaling 34 unique reports. Log-linear modeling estimates 35.8 fatal cases occurred (95% CI, 34-40).
CONCLUSIONS
Chapman's estimates using data collected over 7 years in Florida conclude nHSV infections occurred at a rate of 1 per 3000 live births.

Identifiants

pubmed: 32507882
pii: 5854373
doi: 10.1093/cid/ciaa727
pmc: PMC8935354
mid: NIHMS1783809
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

506-512

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Références

J Chronic Dis. 1974 Feb;27(1):25-36
pubmed: 4815069
Sex Transm Dis. 2019 Feb;46(2):125-131
pubmed: 30640862
Epidemiol Rev. 1995;17(2):243-64
pubmed: 8654510
Pediatrics. 2006 Jun;117(6):1955-62
pubmed: 16740836
Am J Obstet Gynecol. 2007 May;196(5):e55-6
pubmed: 17466681
BMC Public Health. 2014 Feb 11;14:147
pubmed: 24517715
Am J Epidemiol. 2002 May 1;155(9):866-74
pubmed: 11978592
Epidemiol Infect. 2010 Jul;138(7):1052-8
pubmed: 19919729
Sex Transm Dis. 2008 Jan;35(1):14-8
pubmed: 18217222
Pediatrics. 2011 Jan;127(1):e1-8
pubmed: 21149432
J Infect. 2012 Jun;64(6):555-64
pubmed: 22414684
Sex Transm Dis. 2007 Sep;34(9):704-8
pubmed: 17413535
JAMA. 1999 Nov 17;282(19):1845-50
pubmed: 10573276
Pediatr Infect Dis J. 2018 Aug;37(8):806-813
pubmed: 29356762
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1165-70
pubmed: 21622937
Sex Transm Dis. 2008 Jan;35(1):19-21
pubmed: 18157062
JAMA. 2003 Jan 8;289(2):203-9
pubmed: 12517231
Sex Transm Dis. 2011 Aug;38(8):705-11
pubmed: 21844721
Clin Infect Dis. 2014 Aug 15;59(4):525-31
pubmed: 24846638
NCHS Data Brief. 2018 Feb;(304):1-8
pubmed: 29442994
Lancet Glob Health. 2017 Mar;5(3):e300-e309
pubmed: 28153513
Emerg Infect Dis. 2011 Jan;17(1):7-15
pubmed: 21192848
Pediatrics. 2016 Apr;137(4):
pubmed: 26933212
PLoS One. 2016 Aug 16;11(8):e0159832
pubmed: 27529167
Am J Obstet Gynecol. 2006 Feb;194(2):408-14
pubmed: 16458638
Am J Public Health. 2008 Feb;98(2):344-50
pubmed: 18172157
Pediatrics. 2019 Apr;143(4):
pubmed: 30923058
Clin Microbiol Rev. 2004 Jan;17(1):1-13
pubmed: 14726453

Auteurs

James Matthias (J)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Florida Department of Health, Tallahassee, Florida, USA.

Sonya du Bernard (S)

Florida Department of Health, Tallahassee, Florida, USA.

Julia A Schillinger (JA)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
New York City Department of Health and Mental Hygiene, New York City, New York, USA.

Jaeyoung Hong (J)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Victoria Pearson (V)

Florida Department of Health, Tallahassee, Florida, USA.

Thomas A Peterman (TA)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH